ClinicalTrialsFinder

Pancreatic Ductal Adenocarcinoma (mPDAC) Clinical Trials in Seoul, Seoul

1 recruitingSeoul, Seoul, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 1

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

Gastric (Stomach) CancerGastroesophageal CancerPancreatic Ductal Adenocarcinoma (mPDAC)
Dong-A ST Co., Ltd.51 enrolled3 locationsNCT07481357